Main Article Content

Management of chronic hepatitis Band C


G.M. Dusheiko

Abstract

Chronic viral hepatitis caused by hepatitis B, C or 0 may lead to cirrhosis, hepatocellular failure and hepatocellular carcinoma. The morbidity of these diseases has necessitated a prolonged search for effective therapy. Although many antiviral compounds have been evaluated for the treatment of chronic viral hepatitis, few have achieved clinical applicability. Alpha-interferon has been widely studied, and remains the mainstay of treatment. A number of other cytokines, including thymosin, are being evaluated. Nucleoside analogues, alone or in combination with alphainterferon, may prove useful adjuncts to the treatment of chronic hepatitis Band C.


Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574